Efrat BioPolymers

Efrat Biopolymers was an Israeli biotechnology company founded in 1994 by Professor Abraham Domb of the Hebrew University of Jerusalem. The company specialized in the development of biodegradable polymers, particularly polyanhydrides and fatty acid-based polymers, designed for the controlled and localized release of therapeutic agents. Its core technology was aimed at improving the delivery of drugs for indications such as post-operative pain management and localized infections. Efrat Biopolymers was acquired by D-Pharm in 1995, which integrated its polymer expertise into a broader portfolio of drug delivery and neuroprotective platforms. The company's foundational work contributed significantly to the field of biodegradable materials in medical applications.